 |
PDBsum entry 6x1c
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Cell cycle/inhibitor
|
PDB id
|
|
|
|
6x1c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
437 a.a.
|
 |
|
|
|
|
|
|
|
427 a.a.
|
 |
|
|
|
|
|
|
|
121 a.a.
|
 |
|
|
|
|
|
|
|
328 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
X-Ray crystallography-Guided design, Antitumor effica qsar analysis of metabolically stable cyclopenta-Pyri dihydroquinoxalinone as a potent tubulin polymerizati inhibitor.
|
 |
|
Authors
|
 |
S.Banerjee,
F.Mahmud,
S.Deng,
L.Ma,
M.K.Yun,
S.O.Fakayode,
K.E.Arnst,
L.Yang,
H.Chen,
Z.Wu,
P.B.Lukka,
K.Parmar,
B.Meis.W.White,
Y.Wang,
W.Li,
D.D.Miller.
|
 |
|
Ref.
|
 |
j med chem, 2021,
64,
13072.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
No abstract given.
|
 |
|
|
|
|
 |